)
Michelle Duquette
Chief Scientist for Cell Therapy at Invetech, earned her PhD in genetics from Yale University and has over 20 years of experience in genetics, cell biology, and bioengineering, during which she has authored multiple first-author peer-reviewed publications. She also brings 5 years of experience in the cell therapy field, where she has excelled in driving business strategy, establishing strategic partnerships, and providing scientific leadership in automated manufacturing solutions. At Invetech, Michelle collaborates closely with engineers to ensure seamless integration of biological processes with advanced manufacturing technologies. She leads the applications science team, oversees process development and platform demonstrations, and actively contributes to thought leadership through conferences and marketing initiatives. Her expertise bridges technical innovation and client-focused solutions, empowering efficient, high-quality manufacturing processes in the rapidly advancing cell therapy landscape.